Retinitis pigmentosa-17 (RP17) is characterized by relatively mild disease, with decreased visual acuity, visual field constriction, nyctalopia, and slow progression. Many affected individuals have preserved central vision and acuity until the sixth or seventh decades of life (de Bruijn et al., 2020).
For a phenotypic description and a discussion of genetic heterogeneity of retinitis pigmentosa, see 268000. [from
OMIM]